Mankind Pharma Ltd (MANKIND) — Capital Reinvestment Ratio
Mankind Pharma Ltd (MANKIND) has a Capital Reinvestment Ratio of 0.28x as of March 2023, meaning it reinvests 0% of its operating cash flow (Rs4.84 Billion) in capital expenditures (Rs1.33 Billion). See Mankind Pharma Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mankind Pharma Ltd Capital Reinvestment Ratio (2019–2025)
This chart tracks Mankind Pharma Ltd's Capital Reinvestment Ratio across 7 annual periods. Check MANKIND capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Mankind Pharma Ltd (2019–2025)
Year-by-year Capital Reinvestment Ratio for Mankind Pharma Ltd from 2019 to 2025. For live market cap and broader valuation context, see Mankind Pharma Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs24.13 Billion | Rs4.61 Billion | ▲ +7.5% |
| 2024 | 0.18x | Rs21.52 Billion | Rs3.82 Billion | ▼ -61.3% |
| 2023 | 0.46x | Rs18.13 Billion | Rs8.32 Billion | ▼ -82.0% |
| 2022 | 2.55x | Rs9.20 Billion | Rs23.46 Billion | ▲ +828.6% |
| 2021 | 0.27x | Rs11.37 Billion | Rs3.12 Billion | ▲ +28.9% |
| 2020 | 0.21x | Rs10.70 Billion | Rs2.28 Billion | ▼ -57.0% |
| 2019 | 0.50x | Rs6.00 Billion | Rs2.98 Billion | — |